An overview of the preclinical discovery and development of trastuzumab deruxtecan: a novel gastric cancer therapeutic-Reference-Cited by-同舟云学术

An overview of the preclinical discovery and development of trastuzumab deruxtecan: a novel gastric cancer therapeutic

Published:2022-04-15 Issue:5 Volume:17 Page:427-436
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Kalmuk James¹^ORCID,Rinder Dan,Heltzel Carl,Lockhart Albert Craig¹

Affiliation:

1. Department of Hematology/Oncology, Medical University of South Carolina, Walton Research Building, Charleston, SC, USA

Funder

funded

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2022.2050692

Reference63 articles.

1. International agency for research on cancer. globocan 2018. Stomach. 2018 Oct 4. Available from: https://gco.iarc.fr/today/data/fact/sheets/cancers/7-Stomach-fact-sheet.pdf

2. Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer

3. Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatment

4. Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data

5. National Comprehensive Cancer Network. Gastric cancer. Vol. 4 of Clinical practice guidelines in oncology. 2019. [Cited 15 Nov 2021]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER-2 positive gastric cancer: Current targeted treatments;International Journal of Biological Macromolecules;2024-08

2. Antibody-drug conjugates: the clinical development in gastric cancer;Frontiers in Oncology;2023-05-25

3. Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers;Cancers;2023-02-15